EPIQ Capital Group LLC lowered its stake in Quince Therapeutics, Inc. ( NASDAQ:QNCX – Free Report ) by 9.3% in the 1st quarter, HoldingsChannel.com reports. The fund owned 958,469 shares of the company's stock after selling 97,722 shares during the quarter. Quince Therapeutics comprises 0.8% of EPIQ Capital Group LLC's investment portfolio, making the stock its 14th largest holding. EPIQ Capital Group LLC's holdings in Quince Therapeutics were worth $1,495,000 at the end of the most recent quarter.

https://www.dailypolitical.com/2023/08/22/epiq-capital-group-llc-sells-97722-shares-of-quince-therapeutics-inc-nasdaqqncx.html

#dailypolitical